CLINICAL_TRIALS
trial_result
· 2019-09-13
Clinical Trial Update: A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS) [Phase 2]
Summary
Phase 2 MEMOS trial evaluating mifamurtide in advanced osteosarcoma has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Oxford | Conditions: Osteosarcoma | Phase 2 | Status: TERMINATED | Results posted: 2019-09-13